Hurricane Harvey is demonstrating the new world of oil prices–and I’m selling refiner Marathon Petroleum into the storm
With Hurricane Harvey barreling down on the Gulf Coast complex of refineries and oil terminals, you might have expected the price of gasoline to rise yesterday, August 24, on fears of a shutdown of supply. And it did. The price of gasoline climbed 2.35% on the...
Xylem raises guidance for fiscal 2017 after slight earnings beat in second quarter
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
MGM shares climb on news stock is to join S&P 500
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
HAIN spikes 8.56% on news that an activist investor is pressing the company to sell itself
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
Visa: It you can’t beat ’em, buy ’em
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
Adding water play Danaher to my Jubak Picks portfolio
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
Cheniere Energy pops on possibility of increased China exports
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
Incyte dropped 10.5% yesterday on FDA drug “rejection”: Here’s what’s actually going on (and why you shouldn’t sell)
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
Merck writes off $2.9 billion it spent on hepatitis C drug purchased in 2014; here’s who to watch in the biotech sector after this news
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
Is that light at the end of the margin tunnel for Synaptics?
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Great earnings at Alibaba but real worries too
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Jim’s Stock Alerts
Download Jim’s eBook for Free
